 |
Bruton’s tyrosine kinase inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2014-02-10 00:00:00 |
| Sponsor | Celgene Corporation;400 Connell Drive, Suite 700;Berkeley Heights, New Jersey, 07922 |
